Clinical Trial Update: Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of CG0070 for bladder cancer after BCG failure is described; the current status in the entry is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CG0070

Snippet

Sponsor: Cell Genesys | Conditions: Carcinoma, Transitional Cell, Bladder Neoplasms | Phase 1 | Status: UNKNOWN